BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20356415)

  • 21. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yes-associated protein (YAP) expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma.
    Wang S; Li H; Wang G; Zhang T; Fu B; Ma M; Quan Z; Chen G
    Clin Transl Oncol; 2016 Feb; 18(2):172-7. PubMed ID: 26254048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-143-3p inhibits proliferation and invasion of hepatocellular carcinoma cells by regulating its target gene FGF1.
    Peng J; Wu HJ; Zhang HF; Fang SQ; Zeng R
    Clin Transl Oncol; 2021 Mar; 23(3):468-480. PubMed ID: 32617870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSF1 promotes the inhibition of EMT-associated migration by low glucose via directly regulating Snail1 expression in HCC cells.
    Liu D; Sun L; Qin X; Liu T; Zhang S; Liu Y; Li S; Guo K
    Discov Med; 2016 Sep; 22(120):87-96. PubMed ID: 27755964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
    Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.
    Ye T; Xu J; Du L; Mo W; Liang Y; Xia J
    Cell Physiol Biochem; 2017; 41(4):1584-1595. PubMed ID: 28334716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twist expression promotes migration and invasion in hepatocellular carcinoma.
    Matsuo N; Shiraha H; Fujikawa T; Takaoka N; Ueda N; Tanaka S; Nishina S; Nakanishi Y; Uemura M; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yagi T; Yamamoto K
    BMC Cancer; 2009 Jul; 9():240. PubMed ID: 19615090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Asano T; Yamada S; Fuchs BC; Takami H; Hayashi M; Sugimoto H; Fujii T; Tanabe KK; Kodera Y
    Int J Oncol; 2017 May; 50(5):1647-1654. PubMed ID: 28350091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Yang L; Chang Y; Cao P
    Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The down-regulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the cyclooxygenase-2/Snail/E-cadherin pathway in vitro.
    Zhou L; Wang DS; Li QJ; Sun W; Zhang Y; Dou KF
    Dig Dis Sci; 2013 Apr; 58(4):1016-25. PubMed ID: 23053901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion.
    Ru NY; Wu J; Chen ZN; Bian H
    Cell Biol Int; 2015 Jan; 39(1):44-51. PubMed ID: 25044444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail.
    Xia W; Ma X; Li X; Dong H; Yi J; Zeng W; Yang Z
    Oncol Rep; 2015 Aug; 34(2):655-62. PubMed ID: 26035427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
    Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
    Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT.
    Zheng X; Gai X; Wu Z; Liu Q; Yao Y
    Oncol Rep; 2013 May; 29(5):1811-8. PubMed ID: 23483190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
    Lu S; Zhou W; Wei H; He L; Li L
    Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.